What Do Parents of Children with Cancer Search for Online? Published on May 09, 2019 in CHOP News CHOP researchers analyzed online Google searches made by parents of children with cancer. Among other things, parents often focus on ways to best support their child and on day-to-day logistical concerns.
CHOP Announces Citadel as Presenting Sponsor of 2019 Parkway Run & Walk Published on Apr 25, 2019 in CHOP News CHOP announced that Citadel will be the presenting sponsor of its 2019 Parkway Run & walk, taking place Sept. 29, 2019, along the Benjamin Franklin Parkway.
A Cancer-causing Gene May Benefit Patients During Chemotherapy Published on Apr 24, 2019 in CHOP News CHOP researchers report that a well-known gene that normally drives cancer could potentially benefit cancer patients if used in combination with chemotherapy.
Cheers for CHOP Raises $735,000 Published on Mar 06, 2019 in CHOP News Children’s Hospital of Philadelphia’s sixth annual Cheers for CHOP raised $735,000 to support pediatric brain tumor research and care.
Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma Published on Feb 07, 2019 in CHOP News A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.
UAE’s Ministry of Health and Prevention Highlights CHOP's Breakthroughs at Arab Health 2019 Published on Jan 31, 2019 in CHOP News CHOP, a global leader in pediatric healthcare, exhibited some of its leading medical breakthroughs at the annual Arab Health Exhibition and Congress in Dubai.
Immunotherapy: What’s Next for CAR-T Therapy Published on Jan 24, 2019 in Oncology Update, Cancer Connections Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.
Peter Kurre, MD, Appointed Director of the Comprehensive Bone Marrow Failure Center Published on Jan 18, 2019 in CHOP News Dr. Kurre will lead a world-renowned, multidisciplinary team in developing new therapies for BMF syndromes and in basic research.
Humanized CD19: CAR-T Immunotherapy for First Relapse of ALL in Down Syndrome Patient Published on Jan 11, 2019 in Cancer Connections An alternative, humanized CD19 CAR T product for first relapse of pediatric ALL is being evaluated in a clinical trial at Children's Hospital of Philadelphia.
Proton Therapy for Craniopharyngioma Published on Jan 10, 2019 in Cancer Connections Proton therapy at CHOP helped Elena regain her vision and remain free of craniopharyngioma two years after treatment.